Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$213 Sell
2
-4
-67% -$484 ﹤0.01% 931
2026
Q1
$981 Sell
6
-7
-54% -$1.08K ﹤0.01% 885
2025
Q4
$2.26K Buy
13
+11
+550% +$2.01K ﹤0.01% 730
2025
Q3
$288 Hold
2
﹤0.01% 793
2025
Q2
$201 Hold
2
﹤0.01% 816
2025
Q1
$153 Hold
2
﹤0.01% 834
2024
Q4
$138 Buy
+2
New +$144 ﹤0.01% 853

Other funds holding INSM

High Note Wealth's INSM Position: Q2 2026 in Review

High Note Wealth reduced its Insmed (INSM) stake by 67% in Q2 2026, selling an estimated $484 and leaving 2 shares worth $213. The position accounts for ﹤0.01% of the portfolio, ranked #931.

High Note Wealth first reported a position in INSM in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.26K in Q4 2025. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • High Note Wealth held 2 shares of Insmed worth $213 as of Q2 2026.
  • High Note Wealth sold 4 Insmed shares in Q2 2026, an estimated $484.
  • Insmed made up ﹤0.01% of High Note Wealth's portfolio in Q2 2026, its #931 holding.
  • High Note Wealth first reported a position in Insmed in Q4 2024 and has held it in 7 quarters since.
  • High Note Wealth's Insmed position peaked at $2.26K in Q4 2025.
  • 666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on High Note Wealth's 13F filing for Q2 2026, filed 23 Jul 2026.